0

Cell and Gene Therapy Market by Type and Geography - Forecast and Analysis 2022-2026

  • Published: Sep 2022
  • Pages: 138
  • SKU: IRTNTR74196
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The cell and gene therapy market share is expected to increase by USD 9.97 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 20.15%.

This cell and gene therapy market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers cell and gene therapy market segmentations by type (cell therapy and gene therapy) and geography (North America, Europe, Asia, and Rest of World (ROW)). The cell and gene therapy market report also offers information on several market vendors, including Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., bluebird bio Inc., Bristol Myers Squibb Co., Castle Creek Biosciences Inc., CORESTEM Inc., Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC., Ferring BV, Gilead Sciences Inc., Helixmith Co. Ltd., Human Stem Cells Institute, JCR Pharmaceticals Co. Ltd., Kolon TissueGene Inc., Novartis AG, Orchard Therapeutics Plc, Pfizer Inc., Sibiono GeneTech Co. Ltd., and Vericel Corp. among others.

What will the Cell and Gene Therapy Market Size be During the Forecast Period?

Cell and Gene Therapy Market Size

Download Report Sample to Unlock the Cell and Gene Therapy Market Size for the Forecast Period and Other Important Statistics

 

Cell and Gene Therapy Market: Key Drivers, Trends, and Challenges

The increasing prevalence of chronic diseases is notably driving the cell and gene therapy market growth, although factors such as high cost and failure rate in clinical trials may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the cell and gene therapy industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Cell and Gene Therapy Market Driver

  • The increasing prevalence of chronic diseases is one of the factors driving the cell and gene therapy market growth.
  • Chronic diseases present a significant burden on patients and healthcare systems. Moreover, unhealthy lifestyle habits such as the lack of exercise, poor nutrition intake, and substance abuse such as addiction to alcohol and tobacco are the major risk factors resulting in the increasing prevalence of chronic diseases.
  • The incidence of many musculoskeletal disorders and bone injuries such as arthritis, osteoporosis, and serious limb trauma injuries requiring hospitalization is increasing. For instance, in the US, many adults have arthritis and osteoarthritis.
  • Most chronic diseases may result in tissue or organ damage. The vast majority of treatments available for chronic diseases are palliative. 
  • A novel therapeutic approach called gene transfer involves the insertion of new genes into a cancerous cell or the surrounding tissue to cause cell death or reduce the growth of cancer. Thus, these factors will lead to the increased adoption of cell and gene therapies for the treatment of chronic diseases, which, in turn, is expected to drive the growth of the market during the forecast period.

Key Cell and Gene Therapy Market Trend

  • Increasing focus on the development of drugs for emerging applications is one of the key cell and gene therapy market trends fueling the market growth.
  • There has been a growing focus of vendors on developing cell therapies for emerging applications, such as oncology and musculoskeletal disorders. As there is a high unmet medical need for the treatment of such diseases, the approval of effective therapies will likely change market dynamics. 
  • In oncology, there are about 36 molecules in clinical trials across all stages, among which three are in Phase III. Amgen Inc. is currently developing Blinatumomab for the treatment of B-cell non-Hodgkin lymphoma. Bluebird bio-drug candidate, LentiGlobin BB305 drug product, is currently in its Phase III development stage for the treatment of sickle cell disease.
  • Many companies are extensively conducting clinical trials on autologous cell therapy products for the treatment of musculoskeletal disorders. such developments will fuel the market growth in the forecasted period.

Key Cell and Gene Therapy Market Challenge

  • High cost and failure rate in clinical trials is one of the key factors challenging the cell and gene therapy market growth.
  • The cost of conducting clinical trials on cell and gene therapy is high. The high cost may be attributed to the high regulatory requirements, which come with added costs.
  • Multiple clinical trials need to be conducted to test biodistribution, appropriate dosing, delivery timing, tumorigenicity associated with the administered stem cells, and immune rejection. Also, the development of a robust proof-of-concept preclinical model can be costly because it may involve immunomodulation to match the human immune systems.
  • Following the strict regulatory guidelines for compliance in clinical trials is one of the main challenges that companies are facing. This, in turn, will challenge the market growth during the forecast period.

This cell and gene therapy market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global cell and gene therapy market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the cell and gene therapy market during the forecast period.

Who are the Major Cell and Gene Therapy Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

  • Alnylam Pharmaceuticals Inc.
  • Amgen Inc.
  • Biogen Inc.
  • bluebird bio Inc.
  • Bristol Myers Squibb Co.
  • Castle Creek Biosciences Inc.
  • CORESTEM Inc.
  • Cytori Therapeutics Inc.
  • Dendreon Pharmaceuticals LLC.
  • Ferring BV
  • Gilead Sciences Inc.
  • Helixmith Co. Ltd.
  • Human Stem Cells Institute
  • JCR Pharmaceticals Co. Ltd.
  • Kolon TissueGene Inc.
  • Novartis AG
  • Orchard Therapeutics Plc
  • Pfizer Inc.
  • Sibiono GeneTech Co. Ltd.
  • Vericel Corp.

 

This statistical study of the cell and gene therapy market encompasses successful business strategies deployed by the key vendors. The cell and gene therapy market is fragmented and the vendors are deploying growth strategies such as quality, price, market reach, and financial resources to compete in the market.

Product Insights and News

  • Amgen Inc. - The unified segment focuses on discovering, developing, manufacturing, and delivering innovative human therapeutics. 
  • Amgen Inc. - The company offers cell and gene therapeutic solutions that can be incorporated into patients own cytotoxic T cells to help them to recognize and fight cancer cells. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The cell and gene therapy market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Cell and Gene Therapy Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the cell and gene therapy market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for the Cell and Gene Therapy Market?

Cell and Gene Therapy Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

41% of the market’s growth will originate from North America during the forecast period. The US is the key market for the cell and gene therapy market in North America. Market growth in this region will be slower than the growth of the market in Asia.

Huge investment in R&D activities for cell and gene therapy, especially in the US will facilitate the cell and gene therapy market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 had a negative impact on the regional market. However, research institutes and healthcare facilities engaged in gene therapy have started developing new gene therapy products and treatments for individuals with cancer and other rare diseases in 2021. This, in turn, will boost the growth of the regional market during the forecast period.

What are the Revenue-generating Type Segments in the Cell and Gene Therapy Market?

Cell and Gene Therapy Market Share

To gain further insights on the market contribution of various segments Request PDF Sample

The cell and gene therapy market share growth by the cell therapy segment will be significant during the forecast period. Cell therapy is a type of treatment in which living cells are injected into a patient to cure different ailments. The demand for cell therapy treatment is increasing because their products can be used for personalized treatment. The therapeutic benefits of cell therapy products have encouraged companies to develop products from various cell lines such as stem cell-based products. Such factors of cell therapy will boost the market growth in the near future.

This report provides an accurate prediction of the contribution of all the segments to the growth of the cell and gene therapy market size and actionable market insights on post COVID-19 impact on each segment.

 

Cell and Gene Therapy Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 20.15%

Market growth 2022-2026

$ 9.97 billion

Market structure

Fragmented

YoY growth (%)

13.65

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 41%

Key consumer countries

US, Germany, UK, China, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., bluebird bio Inc., Bristol Myers Squibb Co., Castle Creek Biosciences Inc., CORESTEM Inc., Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC., Ferring BV, Gilead Sciences Inc., Helixmith Co. Ltd., Human Stem Cells Institute, JCR Pharmaceticals Co. Ltd., Kolon TissueGene Inc., Novartis AG, Orchard Therapeutics Plc, Pfizer Inc., Sibiono GeneTech Co. Ltd., and Vericel Corp.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Cell and Gene Therapy Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive cell and gene therapy market growth during the next five years
  • Precise estimation of the cell and gene therapy market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the cell and gene therapy industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of cell and gene therapy market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Type

    • 5.1 Market segments
      • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
    • 5.2 Comparison by Type
      • Exhibit 26: Chart on Comparison by Type
      • Exhibit 27: Data Table on Comparison by Type
    • 5.3 Cell therapy - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Cell therapy - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Cell therapy - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Cell therapy - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Cell therapy - Year-over-year growth 2021-2026 (%)
    • 5.4 Gene therapy - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by Type
      • Exhibit 36: Market opportunity by Type ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 40: Chart on Geographic comparison
      • Exhibit 41: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 UK - Market size and forecast 2021-2026
      • Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.10 China - Market size and forecast 2021-2026
      • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.11 Japan - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 78: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 81: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 82: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 83: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 84: Matrix on vendor position and classification
            • 10.3 Amgen Inc.
              • Exhibit 85: Amgen Inc. - Overview
              • Exhibit 86: Amgen Inc. - Product / Service
              • Exhibit 87: Amgen Inc. - Key offerings
            • 10.4 Biogen Inc.
              • Exhibit 88: Biogen Inc. - Overview
              • Exhibit 89: Biogen Inc. - Product / Service
              • Exhibit 90: Biogen Inc. - Key offerings
            • 10.5 bluebird bio Inc.
              • Exhibit 91: bluebird bio Inc. - Overview
              • Exhibit 92: bluebird bio Inc. - Product / Service
              • Exhibit 93: bluebird bio Inc. - Key offerings
            • 10.6 Bristol Myers Squibb Co.
              • Exhibit 94: Bristol Myers Squibb Co. - Overview
              • Exhibit 95: Bristol Myers Squibb Co. - Product / Service
              • Exhibit 96: Bristol Myers Squibb Co. - Key offerings
            • 10.7 CORESTEM Inc.
              • Exhibit 97: CORESTEM Inc. - Overview
              • Exhibit 98: CORESTEM Inc. - Product / Service
              • Exhibit 99: CORESTEM Inc. - Key offerings
            • 10.8 Dendreon Pharmaceuticals LLC.
              • Exhibit 100: Dendreon Pharmaceuticals LLC. - Overview
              • Exhibit 101: Dendreon Pharmaceuticals LLC. - Product / Service
              • Exhibit 102: Dendreon Pharmaceuticals LLC. - Key offerings
            • 10.9 JCR Pharmaceticals Co. Ltd.
              • Exhibit 103: JCR Pharmaceticals Co. Ltd. - Overview
              • Exhibit 104: JCR Pharmaceticals Co. Ltd. - Product / Service
              • Exhibit 105: JCR Pharmaceticals Co. Ltd. - Key offerings
            • 10.10 Novartis AG
              • Exhibit 106: Novartis AG - Overview
              • Exhibit 107: Novartis AG - Business segments
              • Exhibit 108: Novartis AG - Key offerings
              • Exhibit 109: Novartis AG - Segment focus
            • 10.11 Pfizer Inc.
              • Exhibit 110: Pfizer Inc. - Overview
              • Exhibit 111: Pfizer Inc. - Product / Service
              • Exhibit 112: Pfizer Inc. - Key news
              • Exhibit 113: Pfizer Inc. - Key offerings
            • 10.12 Vericel Corp.
              • Exhibit 114: Vericel Corp. - Overview
              • Exhibit 115: Vericel Corp. - Business segments
              • Exhibit 116: Vericel Corp. - Key news
              • Exhibit 117: Vericel Corp. - Key offerings
              • Exhibit 118: Vericel Corp. - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 119: Inclusions checklist
                • Exhibit 120: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 121: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 122: Research methodology
                • Exhibit 123: Validation techniques employed for market sizing
                • Exhibit 124: Information sources
              • 11.5 List of abbreviations
                • Exhibit 125: List of abbreviations
              • health: Includes veterinary drugs (excluded from the scope of the report)

                Research Framework

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                TechnavioINFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases
                Technavio

                TechnavioDATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts
                Technavio

                TechnavioREPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape
                Interested in this report?
                Get your sample now!
                Cell and Gene Therapy market growth will increase by $9974.95 million during 2022-2026.
                The cell and gene therapy market is expected to grow at a CAGR of 20.15% during 2022-2026.
                Technavio has segmented the cell and gene therapy market by geographic (North America, Europe, Asia, and Rest of World (ROW)).
                Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., bluebird bio Inc., Bristol Myers Squibb Co., Castle Creek Biosciences Inc., CORESTEM Inc., Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC., Ferring BV, Gilead Sciences Inc., Helixmith Co. Ltd., Human Stem Cells Institute, JCR Pharmaceticals Co. Ltd., Kolon TissueGene Inc., Novartis AG, Orchard Therapeutics Plc, Pfizer Inc., Sibiono GeneTech Co. Ltd., Vericel Corp. are a few of the key vendors in the cell and gene therapy market.
                North America will register the highest growth rate of 40.52% among the other regions. Therefore, the cell and gene therapy market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
                The key factors driving the cell and gene therapy market growth are:
                • Increasing prevalence of chronic diseases
                • Increasing focus on the development of drugs for emerging applications
                The cell and gene therapy market vendors should focus on grabbing business opportunities from the segment as it accounted for the largest market share in the base year.
                • What are the key global market and the regional market share?
                • What are the revenue-generating key market segments?
                • What are the key factors driving and challenging this market’s growth?
                • Who are the key market vendors and their growth strategies?
                • What are the latest trends influencing the growth of this market?
                • What are the variables influencing the market growth in the primary regions?
                • What are the factors influencing the growth of the parent market?
                • Off-the-shelf research reports
                • Reports can be tailored to meet the customer's needs
                • Trusted by more than 100 fortune 500 organizations
                • Information about the market's key drivers, trends, and challenges
                • Parent market analysis
                • Every week, 50,000 people visit our subscription platform
                • Detailed vendors report with competitive landscape
                • Covid-19 impact and recovery analysis
                • Data on revenue-generating market segments
                • Details on the market shares of various regions
                • Five-force market analysis

                Certified ISO 9001 : 2015

                We are ISO recognized

                We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

                We are GDPR and CCPA compliant

                We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

                Safe and Secure SSL Encrypted
                Technavio

                info
                close
                • Single:

                  One user only.
                  Quick & easy download option

                • Enterprise:

                  Unlimited user access (Within your organization)
                  Complimentary Customization Included

                2500 USD

                Technavio Get the report (PDF) sent to your email within minutes.

                Subscribe & Save

                Get lifetime access to our
                Technavio Insights

                Customized Report as per your Business Needs

                • Our analysts will work directly with you and understand your needs
                • Get data on specified regions or segments, competitor and Vendors
                • Data will be formatted and presented as per your requirements
                • We offer $1000 worth of FREE customization at the time of purchase

                Let us help you make report more suited to your requirements.

                • Get a competitive breakdown as per your niche industry
                • Customize the data with various metrics that meet your business prerequisite
                • Understand Revenue Sources, Customers and many more
                • Details on Market Share
                • These customizations are done in a short amount of time by our analysts and industry experts
                Technavio
                Enquire Before Buying
                17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>